Market Closed -
Swiss Exchange
11:31:30 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
257
CHF
|
+2.11%
|
|
+3.63%
|
-6.34%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
12,863
|
11,231
|
15,781
|
24,153
|
16,147
|
15,324
|
-
|
-
|
Enterprise Value (EV)
1 |
13,116
|
11,894
|
15,864
|
25,161
|
17,643
|
16,584
|
16,536
|
16,441
|
P/E ratio
|
28.2
x
|
23
x
|
27.2
x
|
37.4
x
|
25.1
x
|
26.9
x
|
23.5
x
|
20.6
x
|
Yield
|
1.47%
|
1.66%
|
1.28%
|
1.14%
|
1.71%
|
1.74%
|
1.83%
|
2.05%
|
Capitalization / Revenue
|
4.65
x
|
3.85
x
|
6.07
x
|
7.18
x
|
4.32
x
|
4.17
x
|
3.91
x
|
3.64
x
|
EV / Revenue
|
4.75
x
|
4.08
x
|
6.1
x
|
7.48
x
|
4.72
x
|
4.51
x
|
4.22
x
|
3.91
x
|
EV / EBITDA
|
19.8
x
|
16.7
x
|
18.8
x
|
25.9
x
|
17.9
x
|
17.4
x
|
15.5
x
|
13.9
x
|
EV / FCF
|
31.6
x
|
21.1
x
|
23.5
x
|
30.2
x
|
28
x
|
27.5
x
|
22.6
x
|
19.9
x
|
FCF Yield
|
3.17%
|
4.74%
|
4.26%
|
3.32%
|
3.57%
|
3.64%
|
4.43%
|
5.02%
|
Price to Book
|
5.19
x
|
5.41
x
|
5.74
x
|
9.82
x
|
7.34
x
|
6.26
x
|
5.87
x
|
5.28
x
|
Nbr of stocks (in thousands)
|
65,292
|
64,398
|
63,024
|
62,313
|
60,116
|
59,626
|
-
|
-
|
Reference price
2 |
197.0
|
174.4
|
250.4
|
387.6
|
268.6
|
257.0
|
257.0
|
257.0
|
Announcement Date
|
5/21/19
|
5/19/20
|
5/18/21
|
5/17/22
|
5/16/23
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,763
|
2,917
|
2,602
|
3,364
|
3,738
|
3,674
|
3,922
|
4,207
|
EBITDA
1 |
663.8
|
710.1
|
842.2
|
971.1
|
986.4
|
953.5
|
1,064
|
1,179
|
EBIT
1 |
536.2
|
510
|
619.5
|
760
|
746.7
|
715.6
|
815.9
|
905.1
|
Operating Margin
|
19.41%
|
17.48%
|
23.81%
|
22.59%
|
19.97%
|
19.48%
|
20.8%
|
21.51%
|
Earnings before Tax (EBT)
1 |
529.6
|
502.4
|
600.4
|
728.2
|
715.6
|
704.6
|
806.4
|
922.3
|
Net income
1 |
454.1
|
483.2
|
581
|
649
|
647.5
|
567.9
|
648.4
|
733.7
|
Net margin
|
16.43%
|
16.56%
|
22.33%
|
19.29%
|
17.32%
|
15.46%
|
16.53%
|
17.44%
|
EPS
2 |
6.980
|
7.570
|
9.190
|
10.35
|
10.72
|
9.550
|
10.92
|
12.49
|
Free Cash Flow
1 |
415.3
|
563.7
|
675.2
|
834.5
|
629.6
|
603.1
|
733.3
|
825.1
|
FCF margin
|
15.03%
|
19.32%
|
25.95%
|
24.81%
|
16.84%
|
16.41%
|
18.7%
|
19.61%
|
FCF Conversion (EBITDA)
|
62.56%
|
79.38%
|
80.17%
|
85.93%
|
63.83%
|
63.24%
|
68.93%
|
69.96%
|
FCF Conversion (Net income)
|
91.46%
|
116.66%
|
116.21%
|
128.58%
|
97.24%
|
106.19%
|
113.09%
|
112.45%
|
Dividend per Share
2 |
2.900
|
2.900
|
3.200
|
4.400
|
4.600
|
4.460
|
4.700
|
5.260
|
Announcement Date
|
5/21/19
|
5/19/20
|
5/18/21
|
5/17/22
|
5/16/23
|
-
|
-
|
-
|
Fiscal Period: Maart |
2020 S1
|
2020 S2
|
2021 S1
|
2021 S2
|
2022 S1
|
2022 S2
|
2023 S1
|
2023 S2
|
2024 S1
|
2024 S2
|
---|
Net sales
1 |
1,426
|
1,491
|
1,070
|
1,532
|
1,604
|
1,760
|
1,847
|
1,892
|
1,753
|
2,926
|
EBITDA
|
-
|
368.7
|
327.7
|
514.5
|
477
|
494.1
|
482.8
|
-
|
-
|
-
|
EBIT
1 |
241.2
|
268.8
|
230
|
389.5
|
372.2
|
387.8
|
363.8
|
382.9
|
350
|
892
|
Operating Margin
|
16.91%
|
18.03%
|
21.5%
|
25.42%
|
23.21%
|
22.03%
|
19.7%
|
20.24%
|
19.97%
|
30.49%
|
Earnings before Tax (EBT)
1 |
236
|
266.4
|
219.8
|
-
|
353
|
-
|
350.5
|
365.1
|
293.7
|
883
|
Net income
1 |
355.4
|
127.8
|
204.1
|
376.9
|
294.8
|
354.2
|
291.9
|
355.6
|
249.6
|
771
|
Net margin
|
24.92%
|
8.57%
|
19.08%
|
24.6%
|
18.38%
|
20.12%
|
15.81%
|
18.8%
|
14.24%
|
26.35%
|
EPS
2 |
5.520
|
2.050
|
3.230
|
5.960
|
4.660
|
5.690
|
-
|
5.940
|
4.110
|
4.900
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/19/19
|
5/19/20
|
11/16/20
|
5/18/21
|
11/15/21
|
5/17/22
|
11/14/22
|
5/16/23
|
11/21/23
|
-
|
Fiscal Period: Maart |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
254
|
663
|
83.3
|
1,008
|
1,496
|
1,260
|
1,212
|
1,117
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.3825
x
|
0.9337
x
|
0.0989
x
|
1.038
x
|
1.517
x
|
1.321
x
|
1.14
x
|
0.9474
x
|
Free Cash Flow
1 |
415
|
564
|
675
|
835
|
630
|
603
|
733
|
825
|
ROE (net income / shareholders' equity)
|
18.4%
|
22.1%
|
24.4%
|
25.2%
|
29.1%
|
25.3%
|
26.1%
|
26.9%
|
ROA (Net income/ Total Assets)
|
10.6%
|
11%
|
11.2%
|
11.3%
|
12.1%
|
11.2%
|
12%
|
13.2%
|
Assets
1 |
4,297
|
4,389
|
5,206
|
5,757
|
5,357
|
5,084
|
5,390
|
5,572
|
Book Value Per Share
2 |
38.00
|
32.20
|
43.60
|
39.50
|
36.60
|
41.10
|
43.80
|
48.70
|
Cash Flow per Share
2 |
8.160
|
13.20
|
12.10
|
15.00
|
13.00
|
13.80
|
15.20
|
17.30
|
Capex
1 |
118
|
129
|
89.2
|
107
|
154
|
138
|
147
|
155
|
Capex / Sales
|
4.27%
|
4.42%
|
3.43%
|
3.17%
|
4.13%
|
3.75%
|
3.75%
|
3.68%
|
Announcement Date
|
5/21/19
|
5/19/20
|
5/18/21
|
5/17/22
|
5/16/23
|
-
|
-
|
-
|
Average target price
270.9
CHF Spread / Average Target +5.40% Consensus |
1st Jan change
|
Capi.
|
---|
| -6.34% | 16.75B | | +1.84% | 24.07B | | +10.34% | 10.18B | | -17.75% | 2.06B | | +6.38% | 1.79B | | +41.47% | 1.73B | | +13.26% | 589M | | 0.00% | 400M | | +27.40% | 135M | | +21.80% | 93.49M |
Medical Prosthetics
|